These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30107219)

  • 1. Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation.
    Park SJ; Thapa P; Seo HJ; Park ES; Hoon Jeong S
    Int J Pharm; 2018 Oct; 549(1-2):388-396. PubMed ID: 30107219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects.
    Kim CO; Oh ES; Choi C; Kim Y; Lee S; Kim S; Park MS
    Drug Des Devel Ther; 2016; 10():3763-3770. PubMed ID: 27895466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability.
    Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Song SH; Chae BR; Choi YW
    Int J Pharm; 2016 Jun; 506(1-2):302-11. PubMed ID: 27125455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
    Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
    J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
    Kalgutkar AS; Frederick KS; Hatch HL; Ambler CM; Perry DA; Garigipati RS; Chang GC; Lefker BA; Clark RW; Morehouse LA; Francone O; Hu X
    Xenobiotica; 2014 Jul; 44(7):591-605. PubMed ID: 24380613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous Pravastatin Solid Dispersion Granules Incorporable Into Orally Disintegrating Tablets.
    Song H; Moon C; Lee BJ; Oh E
    J Pharm Sci; 2018 Jul; 107(7):1886-1895. PubMed ID: 29530714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M; Medarević D; Aleksić I; Parojčić J
    Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of eudragit EPO with poloxamers for improved solubility and dissolution of Zafirlukast: An evaluation of solid dispersion formulations.
    Masood Z; Tayyab Ansari M; Afzal S
    Pak J Pharm Sci; 2021 Sep; 34(5(Supplementary)):1923-1928. PubMed ID: 34836861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
    Ali KA; Mukherjee B; Bandyopadhyay AK
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solidification of SMEDDS by fluid bed granulation and manufacturing of fast drug release tablets.
    Mandić J; Pirnat V; Luštrik M; German Ilić I; Vrečer F; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2020 Jun; 583():119377. PubMed ID: 32339633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.